Novo Nordisk successfully prices Euro medium term notes worth EUR 1.3bn

Novo Nordisk has successfully priced EUR 1.3bn (USD 1.6bn) notes, according to a press release published on Thursday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app